REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWO SIGMA ADVISERS, LP | 1,165,700 | $21,518,822 | 0.06% |
| TWINBEECH CAPITAL LP | 167,482 | $3,091,718 | 0.06% |
| CASTLEARK MANAGEMENT LLC | 58,367 | $1,077,455 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 17,900 | $330,434 | 0.05% |
| Flaharty Asset Management, LLC | 13,452 | $248,324 | 0.05% |
| Caption Management, LLC | 147,500 | $2,722,850 | 0.04% |
| XTX Topco Ltd | 10,239 | $189,012 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,026,025 | $37,400,420 | 0.04% |
| Engineers Gate Manager LP | 33,517 | $618,724 | 0.04% |
| Capital World Investors | 9,480,156 | $175,003,680 | 0.04% |
| Ergoteles LLC | 53,078 | $979,820 | 0.04% |
| Allspring Global Investments Holdings, LLC | 1,094,524 | $20,204,912 | 0.03% |
| NOTTINGHAM ADVISORS, INC. | 13,312 | $245,740 | 0.03% |
| CIBC Asset Management Inc | 411,837 | $7,602,511 | 0.03% |
| Accredited Investors Inc. | 20,491 | $378,264 | 0.03% |
| Cubist Systematic Strategies, LLC | 282,827 | $5,220,986 | 0.03% |
| Inspire Investing, LLC | 12,798 | $236,251 | 0.03% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 259,453 | $4,789,502 | 0.03% |
| D. E. Shaw & Co., Inc. | 1,338,920 | $24,716,463 | 0.03% |
| Schonfeld Strategic Advisors LLC | 171,351 | $3,163,139 | 0.03% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.